💨 Abstract

Health Catalyst Inc. (HCAT) reported a Q2 2025 loss of $41 million, or 59 cents per share, but exceeded expectations with adjusted earnings of 4 cents per share, surpassing the anticipated 3 cents. Revenue was $80.7 million, beating the forecasted $80.5 million. For Q3, HCAT anticipates $75 million in revenue, and $310 million for the full year.

Courtesy: WTOP Staff